Alejandro Costaguta

Summary

Publications

  1. doi request reprint Successful treatment of refractory autoimmune hepatitis with rituximab
    Daniel D'Agostino
    Unidad de Hígado y Trasplante Hepático, Sanatorio de Niños, Alvear 863 2000 Rosario, Santa Fe, Argentina
    Pediatrics 132:e526-30. 2013
  2. doi request reprint [The new paradigm of neonatal hemochromatosis: fetal alloimmune hepatitis]
    Alejandro Costaguta
    Unidad de Hígado y Trasplante Hepático, Sanatorio de Niños, Rosario, Argentina
    Arch Argent Pediatr 110:237-43. 2012

Collaborators

  • Daniel D'Agostino
  • Fernando Alvarez

Detail Information

Publications2

  1. doi request reprint Successful treatment of refractory autoimmune hepatitis with rituximab
    Daniel D'Agostino
    Unidad de Hígado y Trasplante Hepático, Sanatorio de Niños, Alvear 863 2000 Rosario, Santa Fe, Argentina
    Pediatrics 132:e526-30. 2013
    ..We describe a new rescue therapy using anti-CD20 monoclonal antibodies (rituximab). Complete remission was obtained and maintained by using low doses of immunosuppressive drugs with repeated anti-CD20 infusions. ..
  2. doi request reprint [The new paradigm of neonatal hemochromatosis: fetal alloimmune hepatitis]
    Alejandro Costaguta
    Unidad de Hígado y Trasplante Hepático, Sanatorio de Niños, Rosario, Argentina
    Arch Argent Pediatr 110:237-43. 2012
    ..This new paradigm produces a deep impact in diagnosis, prognosis and treatment of the disease, that should be called "fetal alloimmune hepatitis"...